More news and press

How Inscripta’s Onyx platform is making creativity the biologist’s only limiting factor
As technology improves and our capabilities increase, biology is moving from gene-scale to genome-scale, think one gene at a time to all…
Read More
Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution
I think the next level of biological discovery is going to be where you can actively perturb the system — it’s called a cell — and then ask what …
Read More
Watch Kevin Ness’ keynote during SynBioBeta 2019: Digital Genome Engineering – Unlocking the Unlimited Potential of Biology
On opening day of SynBioBeta 2019 in San Francisco, CA, Kevin Ness, CEO of Inscripta, announced the company’s Onyx platform: the world’s first…
Read More
Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry
And it’s the application of biology at scale.” This concept was embodied by the headline sponsor, Inscripta, which debuted its Onyx Digital…
Read More
A first-timer’s take on SynBioBeta2019: We can actually build — and are building — a better world
It didn’t take long for that extraordinary evidence to arrive. The first Keynote speaker of the conference, Inscripta’s Kevin Ness, wiped away…
Read More
Technology stands out at synthetic biology conference
Inscripta, based in Boulder, Colorado, debuted a benchtop machine for CRISPR gene editing during SynBioBeta. The machine is designed to edit…
Read More
One-Stop-Shop Genome Editing Product Launched by Inscripta
Inscripta launches a fully automated, benchtop, CRISPR-mediated, genome engineering platform
Read More
Gene editing reborn: A conversation with Inscripta’s Richard Fox
Richard Fox might be the world’s ultimate power user in computational biology, and when he heard about Inscripta’s new technology, he couldn’t…
Read More
Biology Driving Big Changes to Global Economy
Kevin Ness, CEO at Inscripta, on human genomics and the business of gene editing. Hosted by Carol Massar and Jason Kelly.
Read More
Top 10 Companies Leveraging Gene Editing in 2019
In June at the 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) conference in New York City, Inscripta publicly presented for…
Read More
1 of 3